UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000023976
Receipt number R000027599
Scientific Title Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical application
Date of disclosure of the study information 2016/10/01
Last modified on 2020/09/19 01:10:01

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical application

Acronym

Plasma biomarker for Alzheimer's disease

Scientific Title

Plasma biomarker reflecting cerebral amyloid deposition: a multicenter study for the clinical application

Scientific Title:Acronym

Plasma biomarker for Alzheimer's disease

Region

Japan


Condition

Condition

Alzheimer's disease
Other Dementia
Mild cognitive impairment (MCI)
Healthy volunteer

Classification by specialty

Neurology Geriatrics Psychiatry
Radiology Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We have recently developed a novel plasma biomarker capable of highly sensitive detection of brain amyloid deposition (Kaneko et al., Proc Jpn Acad Ser B Phys Biol Sci, 2014). The objective of this study is to validate it's usefulness and plausibility for the clinical application by a multicenter study.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II,III


Assessment

Primary outcomes

The primary endpoint of the study is to evaluate the ability of our plasma biomarkers to estimate the presence (or absence) of brain amyloid deposition, by referring the results of amyloid-PET imaging as the gold standard.

Key secondary outcomes

1) To test quantitative correlation between plasma biomarker values and brain amyloid deposition.
2) To evaluate the performances (e.g. sensitivity and specificity) of the biomarkers for each clinical category
3) Longitudinal changes between the changes in clinical symptoms and biomarker values.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

50 years-old <=

Age-upper limit

100 years-old >=

Gender

Male and Female

Key inclusion criteria

1) Alzheimer's disease (AD)
2) non-AD dementia
3) Mild cognitive impairment (MCI)
4) Healthy volunteer

Having no significant disease and good state of the body condition.

Key exclusion criteria

Having a risk for the MRI measurements, such as a heart pacemaker, implanted body metals, and a nerve stimulator.
Having significant disease.
A history of alcohol or drug addiction.

Target sample size

400


Research contact person

Name of lead principal investigator

1st name Akinori
Middle name
Last name Nakamura

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Clinical and Experimental Neuroimaging

Zip code

474-8511

Address

7-430, Morioka, Obu, Aichi, Japan

TEL

0562-46-2311

Email

nakamura@ncgg.go.jp


Public contact

Name of contact person

1st name Akinori
Middle name
Last name Nakamura

Organization

National Center for Geriatrics and Gerontology

Division name

Department of Clinical and Experimental Neuroimaging

Zip code

474-8511

Address

7-430, Morioka, Obu, Aichi, Japan

TEL

0562-46-2311

Homepage URL


Email

nakamura@ncgg.go.jp


Sponsor or person

Institute

National Center for Geriatrics and Gerontology

Institute

Department

Personal name



Funding Source

Organization

The Japan Agency for Medical Research and Development (AMED)

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor

The Tokyo Metropolitan Institute of Gerontology
Kindai University Hospital
Koichi Tanaka Mass Spectrometry Research Laboratory, Shimadzu Corporation

Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Geriatrics and Gerontology

Address

7-430, Morioka-cho Obu-shi, Aichi 474-8511, Japan

Tel

0562-46-2311

Email

honda-r@ncgg.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立長寿医療研究センター(愛知県)
東京都健康長寿医療センター研究所(東京都)
近畿大学医学部附属病院 早期認知症センター(大阪府)


Other administrative information

Date of disclosure of the study information

2016 Year 10 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Open public recruiting

Date of protocol fixation

2016 Year 09 Month 07 Day

Date of IRB

2016 Year 09 Month 09 Day

Anticipated trial start date

2016 Year 10 Month 01 Day

Last follow-up date

2020 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

This is a multicenter study in Japan. The study design is mainly prospective, but it also analyze available retrospective data sets.


Management information

Registered date

2016 Year 09 Month 08 Day

Last modified on

2020 Year 09 Month 19 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000027599


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name